COMPARISON OF QUALITY OF LIFE AFTER SECONDARY CYTOREDUCTIVE SURGERY (SCS) ± HIPEC IN RECURRENT OVARIAN CANCER

被引：0
|
作者：
Petrillo, M. [1 ]
Costantini, B. [1 ]
Cianci, S. [1 ]
Ronsini, C. [1 ]
Scambia, G. [1 ]
Fagotti, A. [2 ]
机构：
[1] Univ Cattolica Sacro Cuore, Dept Obstet & Gynaecol, I-00168 Rome, Italy
[2] Univ Perugia, Div Minimally Invas Gynaecol Surg, St Maria Hosp, Terni, Italy
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCSM-0109
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [41] Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?
    Zang, Rongyu
    Zhu, Jianqing
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (06)
  • [42] Secondary cytoreductive surgery for recurrent ovarian cancer: who will get the most benefit?
    Son, Joo-Hyuk
    Yum, Sun Hyung
    Kong, Tae-Wook
    Paek, Jiheum
    Chang, Suk-Joon
    Ryu, Hee-Sug
    [J]. GYNECOLOGIC ONCOLOGY, 2021, 162 : S7 - S7
  • [43] Secondary Cytoreductive Surgery in Patients with Platinum-Sensitive Recurrent Ovarian Cancer
    Pierluigi Benedetti Panici
    Antonio De Vivo
    Filippo Bellati
    Natalina Manci
    Giorgia Perniola
    Stefano Basile
    Ludovico Muzii
    Roberto Angioli
    [J]. Annals of Surgical Oncology, 2007, 14 : 1136 - 1142
  • [44] Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer
    Kim, Kidong
    Ryu, Sang-Young
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2009, 30 (03) : 198 - 198
  • [45] Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement
    Harrison, R.
    Zighelboim, I
    Cloven, N. G.
    Marcus, J. Z.
    Coleman, R. L.
    Karam, A.
    [J]. GYNECOLOGIC ONCOLOGY, 2021, 163 (03) : 448 - 452
  • [46] Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer
    Bae, Jaeman
    Lim, Myong Cheol
    Choi, Jae-Ho
    Song, Yong-Joong
    Lee, Kyoung-Soo
    Kang, Sokbom
    Seo, Sang-Soo
    Park, Sang-Yoon
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2009, 20 (02) : 101 - 106
  • [47] Role of cytoreductive surgery in recurrent ovarian cancer
    Harter, Philipp
    Hilpert, Felix
    Mahner, Sven
    Kommoss, Stefan
    Heitz, Florian
    du Bois, Andreas
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (07) : 917 - 922
  • [48] Cytoreductive surgery after recurrent epithelial ovarian cancer and at other timepoints
    Paolo Sammartino
    Tommaso Cornali
    Marialuisa Framarino dei Malatesta
    Pompiliu Piso
    [J]. World Journal of Obstetrics and Gynecology, 2013, (04) : 101 - 107
  • [49] Recurrent Peritoneal Metastases after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer
    Koenigsrainer, I.
    Struller, F.
    Zieker, D.
    Koenigsrainer, A.
    Beckert, S.
    [J]. ZENTRALBLATT FUR CHIRURGIE, 2015, 140 (06): : 607 - 609
  • [50] Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer
    Koole, S. N.
    Kieffer, J. M.
    Sikorska, K.
    van Leeuwen, J. H. Schagen
    Schreuder, H. W. R.
    Hermans, R. H.
    de Hingh, I. H.
    van der Velden, J.
    Arts, H. J.
    van Ham, M. A. P. C.
    Aalbers, A. G.
    Verwaal, V. J.
    Van de Vijver, K. K.
    Sonke, G. S.
    van Driel, W. J.
    Aaronson, N. K.
    [J]. EJSO, 2021, 47 (01): : 101 - 107
12345